Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development

Led by Clarke Capital, the new funding round will accelerate the company's drug discovery pipeline AMERICAN FORK, Utah, Nov. 29, 2023 -- (Healthcare Sales & Marketing Network) -- Biolexis Therapeutics, Inc., a clinical stage AI-driven drug discovery co... Biopharmaceuticals, Venture Capital Biolexis Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news